GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

dostarlimab   Click here for help

GtoPdb Ligand ID: 11518

Synonyms: ANB-011 | dostarlimab-gxly | Jemperli® | TSR-042 | WBP-285
Approved drug Immunopharmacology Ligand
dostarlimab is an approved drug (EMA & FDA (2021))
Compound class: Antibody
Comment: Dostarlimab is a humanized, IgG4κ programmed cell death 1 (PD-1) blocking monoclonal antibody from GlaxoSmithKline.
Classification Click here for help
Compound class Antibody
Ligand families/groups Immune checkpoint modulators
Approved drug? Yes. EU EMA (2021)  |  US FDA (2021)
International Nonproprietary Names Click here for help
INN number INN
10787 dostarlimab
Synonyms Click here for help
ANB-011 | dostarlimab-gxly | Jemperli® | TSR-042 | WBP-285
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 849
Other databases
GtoPdb PubChem SID 441604890
Search PubMed clinical trials dostarlimab
Search PubMed titles dostarlimab
Search PubMed titles/abstracts dostarlimab